Document Detail


Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse.
MedLine Citation:
PMID:  20967535     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
AIMS/HYPOTHESIS: Substantial evidence suggests a link between elevated inflammation and development of insulin resistance. Toll-like receptor 2 (TLR2) recognises a large number of lipid-containing molecules and transduces inflammatory signalling in a variety of cell types, including insulin-responsive cells. Considering the contribution of the fatty acid composition in TLR2-depedent signalling, we hypothesised that the inflammatory signals transduced by TLR2 contribute to insulin resistance.
METHODS: Mice deficient in TLR2 were used to investigate the in vivo roles of TLR2 in initiating and maintaining inflammation-associated insulin resistance and energy homeostasis.
RESULTS: We first recapitulated the observation with elevated expression of TLR2 and inflammatory cytokines in white adipose tissue and liver of ob/ob mice. Aged or high-fat-fed TLR2-deficient mice were protected from obesity and adipocyte hypertrophy compared with wild-type mice. Moreover, mice lacking TLR2 exhibited improved glucose tolerance and insulin sensitivity regardless of feeding them regular chow or a high-fat diet. This is accompanied by reductions in expression of inflammatory cytokines and activation of extracellular signal-regulated kinase (ERK) in a liver-specific manner. The attenuated hepatic inflammatory cytokine expression and related signalling are correlated with increased insulin action specifically in the liver in TLR2-deficient mice, reflected by increased insulin-stimulated protein kinase B (Akt) phosphorylation and IRS1 tyrosine phosphorylation and increased insulin-suppressed hepatocyte glucose production.
CONCLUSIONS/INTERPRETATION: The absence of TLR2 attenuates local inflammatory cytokine expression and related signalling and increases insulin action specifically in the liver. Thus, our work has identified TLR2 as a key mediator of hepatic inflammation-related signalling and insulin resistance.
Authors:
L-H Kuo; P-J Tsai; M-J Jiang; Y-L Chuang; L Yu; K-T A Lai; Y-S Tsai
Related Documents :
19027825 - Genetic polymorphism in long-lived people: cues for the presence of an insulin/igf-path...
16644685 - Methylglyoxal impairs the insulin signaling pathways independently of the formation of ...
19596015 - Transcriptional profiles of adult male and female schistosoma japonicum in response to ...
1735455 - Stimulation of proliferation of hl60 cells by low concentrations of 12-o-tetradecanoylp...
3959895 - Genetics of the spontaneous diabetic syndrome. interaction of mhc and non-mhc-associate...
3042255 - Proinsulin, insulin, and c-peptide in cystic fibrosis after an oral glucose tolerance t...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-10-22
Journal Detail:
Title:  Diabetologia     Volume:  54     ISSN:  1432-0428     ISO Abbreviation:  Diabetologia     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0006777     Medline TA:  Diabetologia     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  168-79     Citation Subset:  IM    
Affiliation:
Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan, Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  [What's new for prevention of thromboembolism in trauma surgery?].
Next Document:  Starvation/stationary-phase survival of Rhodococcus erythropolis SQ1: a physiological and genetic an...